Company profile
Anergis
Anergis proprietary Allergy Vaccines are designed to be safe and require treatment of only 2 months, in comparison to existing desensitization methods which require 3-5 years. By providing dramatic improvements in treatment safety, duration and convenience, with an equivalent or better long term efficacy, Anergis Breakthrough Allergy Vaccines will become a highly attractive alternative to all existing treatment options, with clear benefits to patients, doctors and health care players.
Source: startup.ch